ArticleDiscover mental health2026
Associations of perceived helpfulness of depression treatment modality with symptom severity and substance use disorder.
Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental health treatment use remains low despite increasing major depressive episodes (MDE), suicidality, and substance use disorders (SUD).
aimsTo examine the associations of perceived treatment helpfulness with clinical characteristics (MDE, suicidality, and SUD) and treatment modality (medication, counseling/other treatment [COT], and both treatment [MCOT]).
methodsWe used the 2022 and 2023 U.S. National Survey on Drug Use and Health data on adult depression treatment users (N = 10,221) and multinomial and generalized ordinal logistic regression models.
resultsAmong treatment users, 15% used medication only, 25% used COT only, and 60% used MCOT. Overall, 60% of medication users and 47% of COT users perceived their respective treatments as “a lot” or “extremely” helpful. MDE and suicidality were associated with a higher likelihood of using COT only and/or MCOT. Both MDE and suicidality were associated with lower odds of perceiving treatment as helpful among medication users (OR = 0.47, 95% CI = 0.39–0.57 for MDE; OR = 0.78, 95% CI = 0.66–0.91 for suicidality) as well as COT users (OR = 0.67, 95% CI = 0.56–0.80 for MDE; OR = 0.82, 95% CI = 0.70–0.97 for suicidality). Co-occurring alcohol and drug use disorders were also associated with lower odds of perceived helpfulness among COT users. The use of both medication and COT was associated with higher odds of perceiving either modality as helpful. These patterns did not differ meaningfully for individuals with MDE.
conclusionsThe lower perceived treatment helpfulness among individuals with complex clinical presentations underscores the need for more intensive, personalized, and sustained interventions. Comparison between treatment recipients’ perceived helpfulness and objective clinical effectiveness is also needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.